APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Biologic Therapeutic Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Biologic Therapeutic Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173970690331 December 2025197 pages

Choose your research edition.

Industry ResearchBiologic Therapeutic Drug Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologic Therapeutic Drug Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Biologic Therapeutic Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologic Therapeutic Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Biologic Therapeutic Drug Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Biologic Therapeutic Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Biologic Therapeutic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biologic Therapeutic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biologic Therapeutic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Biologic Therapeutic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biologic Therapeutic Drug include Merck and Co. Inc., Pfizer Inc., AstraZeneca, Smith Medical, Retractable Technologies, Inc., Novartis Global, H. Lundbeck A/S, GlaxoSmithKline Plc. and Concord Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Biologic Therapeutic Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biologic Therapeutic Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biologic Therapeutic Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Biologic Therapeutic Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Biologic Therapeutic Drug Segment by Company

Merck and Co. Inc.

Pfizer Inc.

AstraZeneca

Smith Medical

Retractable Technologies, Inc.

Novartis Global

H. Lundbeck A/S

GlaxoSmithKline Plc.

Concord Biotech

Aurobindo Pharma Ltd.

Biologic Therapeutic Drug Segment by Type

Monoclonal Antibodies

Vaccines

Therapeutic Proteins

Biologic Therapeutic Drug Segment by Application

Clinical Medicine

Laboratory

Others

Biologic Therapeutic Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologic Therapeutic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologic Therapeutic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologic Therapeutic Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Biologic Therapeutic Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biologic Therapeutic Drug industry.

Chapter 3: Detailed analysis of Biologic Therapeutic Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologic Therapeutic Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biologic Therapeutic Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Monoclonal Antibodies Table 3. Key Players of Vaccines Table 4. Key Players of Therapeutic Proteins Table 4. Global Biologic Therapeutic Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Clinical Medicine Table 6. Key Players of Laboratory Table 7. Key Players of Others Table 8. Global Biologic Therapeutic Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Biologic Therapeutic Drug Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Biologic Therapeutic Drug Market Share by Region (2021-2026) Table 11. Global Biologic Therapeutic Drug Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Biologic Therapeutic Drug Market Share by Region (2027-2032) Table 13. Biologic Therapeutic Drug Industry Trends Table 14. Biologic Therapeutic Drug Industry Drivers Table 15. Biologic Therapeutic Drug Industry Opportunities and Challenges Table 16. Biologic Therapeutic Drug Industry Restraints Table 17. Global Biologic Therapeutic Drug Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Biologic Therapeutic Drug Revenue Market Share by Company (2021-2026) Table 19. Global Biologic Therapeutic Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Biologic Therapeutic Drug Key Company Head Office and Area Served Table 21. Global Biologic Therapeutic Drug Company, Product Type & Application Table 22. Global Biologic Therapeutic Drug Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Biologic Therapeutic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Biologic Therapeutic Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Biologic Therapeutic Drug Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Biologic Therapeutic Drug Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Biologic Therapeutic Drug Revenue Market Share by Type (2021-2026) Table 29. Global Biologic Therapeutic Drug Revenue Market Share by Type (2027-2032) Table 30. Global Biologic Therapeutic Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Biologic Therapeutic Drug Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Biologic Therapeutic Drug Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Biologic Therapeutic Drug Revenue Market Share by Application (2021-2026) Table 34. Global Biologic Therapeutic Drug Revenue Market Share by Application (2027-2032) Table 35. Merck and Co. Inc. Company Information Table 36. Merck and Co. Inc. Business Overview Table 37. Merck and Co. Inc. Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Merck and Co. Inc. Biologic Therapeutic Drug Product Portfolio Table 39. Merck and Co. Inc. Recent Development Table 40. Pfizer Inc. Company Information Table 41. Pfizer Inc. Business Overview Table 42. Pfizer Inc. Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Pfizer Inc. Biologic Therapeutic Drug Product Portfolio Table 44. Pfizer Inc. Recent Development Table 45. AstraZeneca Company Information Table 46. AstraZeneca Business Overview Table 47. AstraZeneca Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. AstraZeneca Biologic Therapeutic Drug Product Portfolio Table 49. AstraZeneca Recent Development Table 50. Smith Medical Company Information Table 51. Smith Medical Business Overview Table 52. Smith Medical Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Smith Medical Biologic Therapeutic Drug Product Portfolio Table 54. Smith Medical Recent Development Table 55. Retractable Technologies, Inc. Company Information Table 56. Retractable Technologies, Inc. Business Overview Table 57. Retractable Technologies, Inc. Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Retractable Technologies, Inc. Biologic Therapeutic Drug Product Portfolio Table 59. Retractable Technologies, Inc. Recent Development Table 60. Novartis Global Company Information Table 61. Novartis Global Business Overview Table 62. Novartis Global Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Novartis Global Biologic Therapeutic Drug Product Portfolio Table 64. Novartis Global Recent Development Table 65. H. Lundbeck A/S Company Information Table 66. H. Lundbeck A/S Business Overview Table 67. H. Lundbeck A/S Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. H. Lundbeck A/S Biologic Therapeutic Drug Product Portfolio Table 69. H. Lundbeck A/S Recent Development Table 70. GlaxoSmithKline Plc. Company Information Table 71. GlaxoSmithKline Plc. Business Overview Table 72. GlaxoSmithKline Plc. Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. GlaxoSmithKline Plc. Biologic Therapeutic Drug Product Portfolio Table 74. GlaxoSmithKline Plc. Recent Development Table 75. Concord Biotech Company Information Table 76. Concord Biotech Business Overview Table 77. Concord Biotech Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Concord Biotech Biologic Therapeutic Drug Product Portfolio Table 79. Concord Biotech Recent Development Table 80. Aurobindo Pharma Ltd. Company Information Table 81. Aurobindo Pharma Ltd. Business Overview Table 82. Aurobindo Pharma Ltd. Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Aurobindo Pharma Ltd. Biologic Therapeutic Drug Product Portfolio Table 84. Aurobindo Pharma Ltd. Recent Development Table 85. North America Biologic Therapeutic Drug Market Size by Type (2021-2026) & (US$ Million) Table 86. North America Biologic Therapeutic Drug Market Size by Type (2027-2032) & (US$ Million) Table 87. North America Biologic Therapeutic Drug Market Size by Application (2021-2026) & (US$ Million) Table 88. North America Biologic Therapeutic Drug Market Size by Application (2027-2032) & (US$ Million) Table 89. North America Biologic Therapeutic Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Biologic Therapeutic Drug Market Size by Country (2021-2026) Table 91. North America Biologic Therapeutic Drug Market Size by Country (2027-2032) Table 92. Europe Biologic Therapeutic Drug Market Size by Type (2021-2026) & (US$ Million) Table 93. Europe Biologic Therapeutic Drug Market Size by Type (2027-2032) & (US$ Million) Table 94. Europe Biologic Therapeutic Drug Market Size by Application (2021-2026) & (US$ Million) Table 95. Europe Biologic Therapeutic Drug Market Size by Application (2027-2032) & (US$ Million) Table 96. Europe Biologic Therapeutic Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Biologic Therapeutic Drug Market Size by Country (2021-2026) Table 98. Europe Biologic Therapeutic Drug Market Size by Country (2027-2032) Table 99. China Biologic Therapeutic Drug Market Size by Type (2021-2026) & (US$ Million) Table 100. China Biologic Therapeutic Drug Market Size by Type (2027-2032) & (US$ Million) Table 101. China Biologic Therapeutic Drug Market Size by Application (2021-2026) & (US$ Million) Table 102. China Biologic Therapeutic Drug Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia Biologic Therapeutic Drug Market Size by Type (2021-2026) & (US$ Million) Table 104. Asia Biologic Therapeutic Drug Market Size by Type (2027-2032) & (US$ Million) Table 105. Asia Biologic Therapeutic Drug Market Size by Application (2021-2026) & (US$ Million) Table 106. Asia Biologic Therapeutic Drug Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia Biologic Therapeutic Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Biologic Therapeutic Drug Market Size by Country (2021-2026) Table 109. Asia Biologic Therapeutic Drug Market Size by Country (2027-2032) Table 110. South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Type (2021-2026) & (US$ Million) Table 111. South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Type (2027-2032) & (US$ Million) Table 112. South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Application (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Application (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2021-2026) Table 116. South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Biologic Therapeutic Drug Product Image Figure 2. Global Biologic Therapeutic Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Biologic Therapeutic Drug Market Share by Type: 2025 VS 2032 Figure 4. Monoclonal Antibodies Image Figure 5. Vaccines Image Figure 6. Therapeutic Proteins Image Figure 7. Global Biologic Therapeutic Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Biologic Therapeutic Drug Market Share by Application: 2025 VS 2032 Figure 9. Clinical Medicine Image Figure 10. Laboratory Image Figure 11. Others Image Figure 12. Global Biologic Therapeutic Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 14. Global Biologic Therapeutic Drug Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Biologic Therapeutic Drug Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Biologic Therapeutic Drug Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Biologic Therapeutic Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Biologic Therapeutic Drug Revenue Market Share by Type (2021-2032) Figure 21. Global Biologic Therapeutic Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Biologic Therapeutic Drug Revenue Market Share by Application (2021-2032) Figure 23. North America Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 24. North America Biologic Therapeutic Drug Market Share by Type (2021-2032) Figure 25. North America Biologic Therapeutic Drug Market Share by Application (2021-2032) Figure 26. North America Biologic Therapeutic Drug Market Share by Country (2021-2032) Figure 27. United States Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 28. Canada Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 30. Europe Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 31. Europe Biologic Therapeutic Drug Market Share by Type (2021-2032) Figure 32. Europe Biologic Therapeutic Drug Market Share by Application (2021-2032) Figure 33. Europe Biologic Therapeutic Drug Market Share by Country (2021-2032) Figure 34. Germany Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 35. France Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 37. Italy Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 38. Russia Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 40. China Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 41. China Biologic Therapeutic Drug Market Share by Type (2021-2032) Figure 42. China Biologic Therapeutic Drug Market Share by Application (2021-2032) Figure 43. Asia Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 44. Asia Biologic Therapeutic Drug Market Share by Type (2021-2032) Figure 45. Asia Biologic Therapeutic Drug Market Share by Application (2021-2032) Figure 46. Asia Biologic Therapeutic Drug Market Share by Country (2021-2032) Figure 47. Japan Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 51. India Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 52. Australia Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Biologic Therapeutic Drug Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Biologic Therapeutic Drug Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Biologic Therapeutic Drug Market Share by Country (2021-2032) Figure 57. Brazil Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 62. UAE Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 64. Chile Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibodies
  • Vaccines
  • Therapeutic Proteins
Applications
  • Clinical Medicine
  • Laboratory
  • Others
Companies covered
  • Merck and Co. Inc.
  • Pfizer Inc.
  • AstraZeneca
  • Smith Medical
  • Retractable Technologies, Inc.
  • Novartis Global
  • H. Lundbeck A/S
  • GlaxoSmithKline Plc.
  • Concord Biotech
  • Aurobindo Pharma Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Biologic Therapeutic Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Monoclonal Antibodies
  5. 1.2.3 Vaccines
  6. 1.2.4 Therapeutic Proteins
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Biologic Therapeutic Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Clinical Medicine
  10. 1.3.3 Laboratory
  11. 1.3.4 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Biologic Therapeutic Drug Growth Trends by Region
  14. 1.5.1 Global Biologic Therapeutic Drug Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Biologic Therapeutic Drug Market Size by Region (2021-2026)
  16. 1.5.3 Biologic Therapeutic Drug Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Biologic Therapeutic Drug Market Dynamics
  1. 2.1 Biologic Therapeutic Drug Industry Trends
  2. 2.2 Biologic Therapeutic Drug Industry Drivers
  3. 2.3 Biologic Therapeutic Drug Industry Opportunities and Challenges
  4. 2.4 Biologic Therapeutic Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Biologic Therapeutic Drug Revenue by Company (2021-2026)
  2. 3.2 Global Biologic Therapeutic Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Biologic Therapeutic Drug Key Company Head office and Area Served
  4. 3.4 Global Biologic Therapeutic Drug Company, Product Type & Application
  5. 3.5 Global Biologic Therapeutic Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Biologic Therapeutic Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Biologic Therapeutic Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Biologic Therapeutic Drug Tier 1, Tier 2, and Tier 3
4 Biologic Therapeutic Drug Market by Type
  1. 4.1 Global Biologic Therapeutic Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Biologic Therapeutic Drug Market Size by Type (2021-2032)
  3. 4.3 Global Biologic Therapeutic Drug Market Size Share by Type (2021-2032)
5 Biologic Therapeutic Drug Market by Application
  1. 5.1 Global Biologic Therapeutic Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Biologic Therapeutic Drug Market Size by Application (2021-2032)
  3. 5.3 Global Biologic Therapeutic Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Merck and Co. Inc.
  2. 6.1.1 Merck and Co. Inc. Company Information
  3. 6.1.2 Merck and Co. Inc. Business Overview
  4. 6.1.3 Merck and Co. Inc. Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Merck and Co. Inc. Biologic Therapeutic Drug Product Portfolio
  6. 6.1.5 Merck and Co. Inc. Recent Developments
  7. 6.2 Pfizer Inc.
  8. 6.2.1 Pfizer Inc. Company Information
  9. 6.2.2 Pfizer Inc. Business Overview
  10. 6.2.3 Pfizer Inc. Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Pfizer Inc. Biologic Therapeutic Drug Product Portfolio
  12. 6.2.5 Pfizer Inc. Recent Developments
  13. 6.3 AstraZeneca
  14. 6.3.1 AstraZeneca Company Information
  15. 6.3.2 AstraZeneca Business Overview
  16. 6.3.3 AstraZeneca Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 AstraZeneca Biologic Therapeutic Drug Product Portfolio
  18. 6.3.5 AstraZeneca Recent Developments
  19. 6.4 Smith Medical
  20. 6.4.1 Smith Medical Company Information
  21. 6.4.2 Smith Medical Business Overview
  22. 6.4.3 Smith Medical Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Smith Medical Biologic Therapeutic Drug Product Portfolio
  24. 6.4.5 Smith Medical Recent Developments
  25. 6.5 Retractable Technologies, Inc.
  26. 6.5.1 Retractable Technologies, Inc. Company Information
  27. 6.5.2 Retractable Technologies, Inc. Business Overview
  28. 6.5.3 Retractable Technologies, Inc. Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Retractable Technologies, Inc. Biologic Therapeutic Drug Product Portfolio
  30. 6.5.5 Retractable Technologies, Inc. Recent Developments
  31. 6.6 Novartis Global
  32. 6.6.1 Novartis Global Company Information
  33. 6.6.2 Novartis Global Business Overview
  34. 6.6.3 Novartis Global Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Novartis Global Biologic Therapeutic Drug Product Portfolio
  36. 6.6.5 Novartis Global Recent Developments
  37. 6.7 H. Lundbeck A/S
  38. 6.7.1 H. Lundbeck A/S Company Information
  39. 6.7.2 H. Lundbeck A/S Business Overview
  40. 6.7.3 H. Lundbeck A/S Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 H. Lundbeck A/S Biologic Therapeutic Drug Product Portfolio
  42. 6.7.5 H. Lundbeck A/S Recent Developments
  43. 6.8 GlaxoSmithKline Plc.
  44. 6.8.1 GlaxoSmithKline Plc. Company Information
  45. 6.8.2 GlaxoSmithKline Plc. Business Overview
  46. 6.8.3 GlaxoSmithKline Plc. Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 GlaxoSmithKline Plc. Biologic Therapeutic Drug Product Portfolio
  48. 6.8.5 GlaxoSmithKline Plc. Recent Developments
  49. 6.9 Concord Biotech
  50. 6.9.1 Concord Biotech Company Information
  51. 6.9.2 Concord Biotech Business Overview
  52. 6.9.3 Concord Biotech Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Concord Biotech Biologic Therapeutic Drug Product Portfolio
  54. 6.9.5 Concord Biotech Recent Developments
  55. 6.10 Aurobindo Pharma Ltd.
  56. 6.10.1 Aurobindo Pharma Ltd. Company Information
  57. 6.10.2 Aurobindo Pharma Ltd. Business Overview
  58. 6.10.3 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Product Portfolio
  60. 6.10.5 Aurobindo Pharma Ltd. Recent Developments
7 North America
  1. 7.1 North America Biologic Therapeutic Drug Market Size (2021-2032)
  2. 7.2 North America Biologic Therapeutic Drug Market Size by Type
  3. 7.2.1 North America Biologic Therapeutic Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Biologic Therapeutic Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Biologic Therapeutic Drug Market Share by Type (2021-2032)
  6. 7.3 North America Biologic Therapeutic Drug Market Size by Application
  7. 7.3.1 North America Biologic Therapeutic Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Biologic Therapeutic Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Biologic Therapeutic Drug Market Share by Application (2021-2032)
  10. 7.4 North America Biologic Therapeutic Drug Market Size by Country
  11. 7.4.1 North America Biologic Therapeutic Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Biologic Therapeutic Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Biologic Therapeutic Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Biologic Therapeutic Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Biologic Therapeutic Drug Market Size (2021-2032)
  2. 8.2 Europe Biologic Therapeutic Drug Market Size by Type
  3. 8.2.1 Europe Biologic Therapeutic Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Biologic Therapeutic Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Biologic Therapeutic Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Biologic Therapeutic Drug Market Size by Application
  7. 8.3.1 Europe Biologic Therapeutic Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Biologic Therapeutic Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Biologic Therapeutic Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Biologic Therapeutic Drug Market Size by Country
  11. 8.4.1 Europe Biologic Therapeutic Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Biologic Therapeutic Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Biologic Therapeutic Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Biologic Therapeutic Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Biologic Therapeutic Drug Market Size (2021-2032)
  2. 9.2 China Biologic Therapeutic Drug Market Size by Type
  3. 9.2.1 China Biologic Therapeutic Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Biologic Therapeutic Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Biologic Therapeutic Drug Market Share by Type (2021-2032)
  6. 9.3 China Biologic Therapeutic Drug Market Size by Application
  7. 9.3.1 China Biologic Therapeutic Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Biologic Therapeutic Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Biologic Therapeutic Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Biologic Therapeutic Drug Market Size (2021-2032)
  2. 10.2 Asia Biologic Therapeutic Drug Market Size by Type
  3. 10.2.1 Asia Biologic Therapeutic Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Biologic Therapeutic Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Biologic Therapeutic Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Biologic Therapeutic Drug Market Size by Application
  7. 10.3.1 Asia Biologic Therapeutic Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Biologic Therapeutic Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Biologic Therapeutic Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Biologic Therapeutic Drug Market Size by Country
  11. 10.4.1 Asia Biologic Therapeutic Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Biologic Therapeutic Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Biologic Therapeutic Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Biologic Therapeutic Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Biologic Therapeutic Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Biologic Therapeutic Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Biologic Therapeutic Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Biologic Therapeutic Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst